Genenta Science SPA (FRA:K5F) Moat Score: 5/10 (As of Jul. 09, 2026)


FRA:K5F Genenta Science SPA FRA:K5F
31 GF Score
Price €1.33
! 4 Warning Signs
View Full Analysis

What is Genenta Science SPA Moat Score?

Genenta Science SPA FRA:K5F -3.62% 31 Moat Score is 5 as of Jul. 09, 2026. GuruFocus rates FRA:K5F with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 1,393 Biotechnology companies, Genenta Science SPA ranks better than 96.7% on this metric.

Genenta Science SPA has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Genenta Science SPA has Narrow Moat: Genenta Science SPA has a solid narrow moat due to its innovative R&D capabilities and valuable intellectual property in the biotech sector. However, it faces significant competition and regulatory challenges, limiting its market leadership.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Genenta Science SPA might have Narrow Moat - Solid narrow moat.

Genenta Science SPA  (FRA:K5F) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Genenta Science SPA Moat Score Related Terms

FRA:K5F vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Genenta Science SPA's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Moat Score distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Moat Score falls into.


FRA:K5F
31GF Score
Genenta Science SPA FRA:K5F
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Genenta Science SPA (FRA:K5F) has a Moat Score of 5 as of Jul. 09, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Genenta Science SPA ranks #46 out of 1393 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Genenta Science SPA's Moat Score too high?
Genenta Science SPA's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Genenta Science SPA's value of 5 is 150% above this industry median. Based on the distribution chart, Genenta Science SPA ranks #46 out of 1393 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Genenta Science SPA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genenta Science SPA ranks #46 out of 1393 companies for Moat Score. This places Genenta Science SPA in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Genenta Science SPA's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,393 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genenta Science SPA's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genenta Science SPA's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (FRA:K5F) has a current Moat Score of 5. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Genenta Science SPA's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Genenta Science SPA (FRA:K5F), the current Moat Score is 5 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genenta Science SPA Business Description

Other Exchanges GNTA:USA
Address Via dell’Annunciata No. 31, Milan, ITA, 20121
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
31GF Score

Get the complete analysis for FRA:K5F

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.33
Price